| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
|
Science
|
2011
|
10.26
|
|
2
|
Detection of circulating tumor DNA in early- and late-stage human malignancies.
|
Sci Transl Med
|
2014
|
8.36
|
|
3
|
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.
|
Nature
|
2012
|
8.31
|
|
4
|
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas.
|
Pancreatology
|
2012
|
7.22
|
|
5
|
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
|
Sci Transl Med
|
2011
|
5.03
|
|
6
|
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.
|
Proc Natl Acad Sci U S A
|
2011
|
3.51
|
|
7
|
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.
|
J Clin Oncol
|
2008
|
3.51
|
|
8
|
Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer.
|
Ann Surg Oncol
|
2008
|
3.14
|
|
9
|
MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls.
|
Clin Cancer Res
|
2013
|
2.71
|
|
10
|
Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis.
|
Ann Surg
|
2012
|
2.48
|
|
11
|
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
|
Clin Cancer Res
|
2009
|
2.44
|
|
12
|
Is there a difference in survival between right- versus left-sided colon cancers?
|
Ann Surg Oncol
|
2008
|
2.43
|
|
13
|
Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors.
|
J Am Coll Surg
|
2012
|
2.29
|
|
14
|
miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.
|
Clin Cancer Res
|
2012
|
2.10
|
|
15
|
Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer.
|
AJR Am J Roentgenol
|
2015
|
2.00
|
|
16
|
Pancreatic resection of isolated metastases from nonpancreatic primary cancers.
|
Ann Surg Oncol
|
2008
|
1.97
|
|
17
|
The role of surgery in the management of isolated metastases to the pancreas.
|
Lancet Oncol
|
2009
|
1.94
|
|
18
|
EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors.
|
Gastrointest Endosc
|
2010
|
1.91
|
|
19
|
Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis.
|
J Gastrointest Surg
|
2007
|
1.87
|
|
20
|
Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis.
|
HPB (Oxford)
|
2011
|
1.82
|
|
21
|
Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
|
Ann Surg Oncol
|
2010
|
1.79
|
|
22
|
A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.
|
Ann Surg
|
2014
|
1.76
|
|
23
|
Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
|
Am J Surg Pathol
|
2012
|
1.71
|
|
24
|
Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series.
|
J Am Coll Surg
|
2009
|
1.67
|
|
25
|
Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial.
|
J Gastrointest Surg
|
2006
|
1.65
|
|
26
|
Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma.
|
J Gastrointest Surg
|
2012
|
1.64
|
|
27
|
Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy.
|
J Am Coll Surg
|
2011
|
1.64
|
|
28
|
Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas.
|
Ann Surg Oncol
|
2010
|
1.60
|
|
29
|
Acinar cell carcinoma of the pancreas: computed tomography features--a study of 15 patients.
|
Abdom Imaging
|
2013
|
1.59
|
|
30
|
Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system.
|
Arch Surg
|
2011
|
1.59
|
|
31
|
The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma.
|
Ann Surg Oncol
|
2014
|
1.58
|
|
32
|
Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas.
|
Ann Surg
|
2010
|
1.56
|
|
33
|
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
|
Cancer
|
2014
|
1.55
|
|
34
|
Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies.
|
J Am Coll Surg
|
2012
|
1.55
|
|
35
|
Treating patients with colon cancer liver metastasis: a nationwide analysis of therapeutic decision making.
|
Ann Surg Oncol
|
2012
|
1.50
|
|
36
|
Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing.
|
Clin Cancer Res
|
2012
|
1.47
|
|
37
|
Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP.
|
Ann Surg
|
2013
|
1.45
|
|
38
|
A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer.
|
HPB (Oxford)
|
2012
|
1.45
|
|
39
|
Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion.
|
HPB (Oxford)
|
2011
|
1.44
|
|
40
|
Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent.
|
Cancer
|
2011
|
1.43
|
|
41
|
Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors.
|
Clin Cancer Res
|
2012
|
1.37
|
|
42
|
National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis.
|
J Gastrointest Surg
|
2010
|
1.36
|
|
43
|
PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.
|
J Immunother
|
2015
|
1.35
|
|
44
|
A systematic review of solid-pseudopapillary neoplasms: are these rare lesions?
|
Pancreas
|
2014
|
1.35
|
|
45
|
Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis.
|
J Gastrointest Surg
|
2010
|
1.33
|
|
46
|
Choledochal cyst disease in children and adults: a 30-year single-institution experience.
|
J Am Coll Surg
|
2008
|
1.29
|
|
47
|
Adult pancreatic hemangioma: case report and literature review.
|
Gastroenterol Res Pract
|
2009
|
1.27
|
|
48
|
Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature.
|
J Gastrointest Surg
|
2007
|
1.26
|
|
49
|
Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
|
Am J Surg Pathol
|
2013
|
1.25
|
|
50
|
Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment.
|
Ann Surg Oncol
|
2011
|
1.24
|
|
51
|
Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience.
|
J Gastrointest Surg
|
2008
|
1.23
|
|
52
|
The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.
|
Am J Clin Oncol
|
2015
|
1.23
|
|
53
|
Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
|
Ann Surg
|
2009
|
1.22
|
|
54
|
Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio.
|
J Gastrointest Surg
|
2008
|
1.22
|
|
55
|
Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results.
|
J Clin Oncol
|
2013
|
1.22
|
|
56
|
Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.
|
J Pathol
|
2014
|
1.22
|
|
57
|
Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.
|
Ann Surg
|
2012
|
1.22
|
|
58
|
Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.
|
Am J Surg Pathol
|
2014
|
1.17
|
|
59
|
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.
|
Cancer
|
2013
|
1.16
|
|
60
|
Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis.
|
J Am Coll Surg
|
2013
|
1.14
|
|
61
|
Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms.
|
Pancreas
|
2013
|
1.14
|
|
62
|
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients.
|
Hum Pathol
|
2009
|
1.13
|
|
63
|
Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis.
|
Ann Surg
|
2010
|
1.13
|
|
64
|
Understanding surgical decision making in early hepatocellular carcinoma.
|
J Clin Oncol
|
2011
|
1.12
|
|
65
|
Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
|
Radiat Oncol
|
2011
|
1.10
|
|
66
|
Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study.
|
J Gastrointest Surg
|
2010
|
1.10
|
|
67
|
Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
|
Cancer
|
2007
|
1.08
|
|
68
|
Risk factors for pancreatic leak after distal pancreatectomy.
|
Ann Surg
|
2009
|
1.08
|
|
69
|
Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival.
|
J Gastrointest Surg
|
2011
|
1.07
|
|
70
|
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors.
|
Mod Pathol
|
2012
|
1.06
|
|
71
|
Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis.
|
Ann Surg
|
2013
|
1.04
|
|
72
|
Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas.
|
Mod Pathol
|
2011
|
1.04
|
|
73
|
Pancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production?
|
Radiology
|
2010
|
1.04
|
|
74
|
Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective.
|
J Surg Oncol
|
2009
|
1.04
|
|
75
|
National trends in surgical procedures for hepatocellular carcinoma: 1998-2008.
|
Cancer
|
2011
|
1.04
|
|
76
|
Variations in referral patterns to high-volume centers for pancreatic cancer.
|
J Am Coll Surg
|
2009
|
1.01
|
|
77
|
CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis.
|
Clin Cancer Res
|
2012
|
1.00
|
|
78
|
Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm?
|
J Am Coll Surg
|
2013
|
0.99
|
|
79
|
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer.
|
Ann Surg Oncol
|
2011
|
0.99
|
|
80
|
Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.
|
Ann Surg
|
2016
|
0.99
|
|
81
|
Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas.
|
Hum Pathol
|
2011
|
0.99
|
|
82
|
2564 resected periampullary adenocarcinomas at a single institution: trends over three decades.
|
HPB (Oxford)
|
2013
|
0.99
|
|
83
|
Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma.
|
J Surg Oncol
|
2011
|
0.99
|
|
84
|
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients with Pancreatic Adenocarcinoma.
|
Ann Surg
|
2016
|
0.98
|
|
85
|
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.
|
Ann Surg Oncol
|
2015
|
0.97
|
|
86
|
Surgical management of giant Brunner's gland hamartoma: case report and literature review.
|
World J Surg Oncol
|
2009
|
0.97
|
|
87
|
Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer.
|
J Gastrointest Surg
|
2012
|
0.96
|
|
88
|
Solid pseudopapillary neoplasms of the pancreas.
|
Adv Surg
|
2009
|
0.96
|
|
89
|
Cystic pancreatic neuroendocrine tumors: a clinicopathologic study.
|
Am J Surg Pathol
|
2012
|
0.95
|
|
90
|
A risk model to predict 90-day mortality among patients undergoing hepatic resection.
|
J Am Coll Surg
|
2013
|
0.95
|
|
91
|
Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms.
|
Am J Gastroenterol
|
2011
|
0.95
|
|
92
|
Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors.
|
J Gastrointest Surg
|
2014
|
0.94
|
|
93
|
Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies.
|
J Gastrointest Surg
|
2013
|
0.94
|
|
94
|
Provider versus patient factors impacting hospital length of stay after pancreaticoduodenectomy.
|
Surgery
|
2013
|
0.94
|
|
95
|
Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation.
|
Pract Radiat Oncol
|
2012
|
0.94
|
|
96
|
Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma.
|
Cancer Biol Ther
|
2012
|
0.94
|
|
97
|
Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia.
|
J Gastrointest Surg
|
2015
|
0.93
|
|
98
|
Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis.
|
Ann Surg Oncol
|
2012
|
0.93
|
|
99
|
GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".
|
Am J Surg Pathol
|
2014
|
0.92
|
|
100
|
Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT.
|
AJR Am J Roentgenol
|
2013
|
0.92
|
|
101
|
A tolerability and pharmacokinetic study of adjuvant erlotinib and capecitabine with concurrent radiation in resected pancreatic cancer.
|
Transl Oncol
|
2010
|
0.90
|
|
102
|
Surgical resection of malignant melanoma metastatic to the pancreas: case series and review of literature.
|
J Gastrointest Cancer
|
2012
|
0.90
|
|
103
|
Pancreatic imaging mimics: part 2, pancreatic neuroendocrine tumors and their mimics.
|
AJR Am J Roentgenol
|
2012
|
0.90
|
|
104
|
Multidisciplinary management of pancreatic cancer.
|
Surg Oncol Clin N Am
|
2013
|
0.90
|
|
105
|
Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience.
|
J Gastrointest Surg
|
2011
|
0.89
|
|
106
|
Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.89
|
|
107
|
The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy.
|
HPB (Oxford)
|
2014
|
0.88
|
|
108
|
Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.88
|
|
109
|
Readmission incidence and associated factors after a hepatic resection at a major hepato-pancreatico-biliary academic centre.
|
HPB (Oxford)
|
2014
|
0.87
|
|
110
|
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
|
Ann Surg
|
2016
|
0.87
|
|
111
|
Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement.
|
Hum Pathol
|
2012
|
0.87
|
|
112
|
Patient- and cyst-related factors for improved prediction of malignancy within cystic lesions of the pancreas.
|
Pancreatology
|
2009
|
0.87
|
|
113
|
Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis.
|
Am J Surg Pathol
|
2011
|
0.86
|
|
114
|
EUS-guided tattooing before laparoscopic distal pancreatic resection (with video).
|
Gastrointest Endosc
|
2010
|
0.86
|
|
115
|
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.86
|
|
116
|
Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases.
|
Surgery
|
2013
|
0.86
|
|
117
|
Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis.
|
J Surg Oncol
|
2010
|
0.86
|
|
118
|
Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT.
|
AJR Am J Roentgenol
|
2013
|
0.86
|
|
119
|
Hilar cholangiocarcinoma: tumor depth as a predictor of outcome.
|
Arch Surg
|
2011
|
0.85
|
|
120
|
Solid-pseudopapillary neoplasm of the pancreas: spectrum of findings on multidetector CT.
|
Clin Imaging
|
2011
|
0.85
|
|
121
|
Trends and risk factors for transfusion in hepatopancreatobiliary surgery.
|
J Gastrointest Surg
|
2013
|
0.84
|
|
122
|
Vascular invasion in infiltrating ductal adenocarcinoma of the pancreas can mimic pancreatic intraepithelial neoplasia: a histopathologic study of 209 cases.
|
Am J Surg Pathol
|
2012
|
0.84
|
|
123
|
Which patients with resectable pancreatic cancer truly benefit from oncological resection: is it destiny or biology?
|
Cancer Biol Ther
|
2015
|
0.84
|
|
124
|
Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms.
|
Liver Transpl
|
2014
|
0.83
|
|
125
|
Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.83
|
|
126
|
Regulation of expression of the SN1 transporter during renal adaptation to chronic metabolic acidosis in rats.
|
Am J Physiol Renal Physiol
|
2002
|
0.83
|
|
127
|
Unnecessary tests and procedures in patients presenting with solid tumors of the pancreas.
|
J Gastrointest Surg
|
2013
|
0.82
|
|
128
|
The diagnosis and surgical treatment of pancreatoblastoma in adults: a case series and review of the literature.
|
J Gastrointest Surg
|
2013
|
0.82
|
|
129
|
The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma.
|
World J Surg
|
2011
|
0.82
|
|
130
|
Benign pancreatic tumors.
|
Surg Clin North Am
|
2007
|
0.82
|
|
131
|
Hospital volume and patient outcomes in hepato-pancreatico-biliary surgery: is assessing differences in mortality enough?
|
J Gastrointest Surg
|
2014
|
0.82
|
|
132
|
Defining incidence and risk factors of venous thromboemolism after hepatectomy.
|
J Gastrointest Surg
|
2013
|
0.82
|
|
133
|
Anatomical Resections Improve Disease-Free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
|
Ann Surg
|
2017
|
0.81
|
|
134
|
Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning.
|
Radiother Oncol
|
2012
|
0.81
|
|
135
|
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.
|
J Gastrointest Oncol
|
2013
|
0.81
|
|
136
|
Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management.
|
Ann Surg
|
2016
|
0.81
|
|
137
|
Institutional experience with solid pseudopapillary neoplasms: focus on computed tomography, magnetic resonance imaging, conventional ultrasound, endoscopic ultrasound, and predictors of aggressive histology.
|
J Comput Assist Tomogr
|
2013
|
0.81
|
|
138
|
Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery.
|
Surg Endosc
|
2013
|
0.80
|
|
139
|
Young patients undergoing resection of pancreatic cancer fare better than their older counterparts.
|
J Gastrointest Surg
|
2012
|
0.80
|
|
140
|
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.80
|
|
141
|
Acinar cell cystadenoma of the pancreas: a benign neoplasm or non-neoplastic ballooning of acinar and ductal epithelium?
|
Am J Surg Pathol
|
2013
|
0.80
|
|
142
|
Irreversible electroporation: a novel pancreatic cancer therapy.
|
Curr Probl Cancer
|
2013
|
0.80
|
|
143
|
Sclerosing mesenteritis involving the pancreas: a mimicker of pancreatic cancer.
|
Am J Surg Pathol
|
2010
|
0.80
|
|
144
|
Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.
|
Ann Surg
|
2016
|
0.80
|
|
145
|
Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer.
|
J Natl Compr Canc Netw
|
2014
|
0.79
|
|
146
|
Activation of intestinal arginine transport by protein kinase C is mediated by mitogen-activated protein kinases.
|
J Gastrointest Surg
|
2002
|
0.79
|
|
147
|
Serum miR-1290 as a marker of pancreatic cancer--response.
|
Clin Cancer Res
|
2013
|
0.79
|
|
148
|
Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation.
|
Ann Surg
|
2016
|
0.78
|
|
149
|
Fine needle aspirate of autoimmune pancreatitis (lymphoplasmacytic sclerosing pancreatitis): cytomorphologic characteristics and clinical correlates.
|
Acta Cytol
|
2012
|
0.78
|
|
150
|
Is It Time to Expand the Role of Total Pancreatectomy for IPMN?
|
Dig Surg
|
2016
|
0.78
|
|
151
|
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer.
|
Indian J Surg Oncol
|
2011
|
0.78
|
|
152
|
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
|
Ann Surg
|
2017
|
0.77
|
|
153
|
Duodenal neuroendocrine tumors: retrospective evaluation of CT imaging features and pattern of metastatic disease on dual-phase MDCT with pathologic correlation.
|
Abdom Imaging
|
2015
|
0.77
|
|
154
|
Prognosis of minimally invasive carcinoma arising in mucinous cystic neoplasms of the pancreas.
|
Am J Surg Pathol
|
2013
|
0.77
|
|
155
|
Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy.
|
Ann Surg
|
2017
|
0.77
|
|
156
|
Posttranslational alanine trans-stimulation of zwitterionic amino acid transport systems in human intestinal Caco-2 cells.
|
J Surg Res
|
2002
|
0.77
|
|
157
|
Irreversible electroporation: a novel therapy for stage III pancreatic cancer.
|
Adv Surg
|
2014
|
0.77
|
|
158
|
Smoking is not associated with severe dysplasia or invasive carcinoma in resected intraductal papillary mucinous neoplasms.
|
J Gastrointest Surg
|
2014
|
0.75
|
|
159
|
Diffusion-Weighted Magnetic Resonance Imaging in Distinguishing Between Mucin-Producing and Serous Pancreatic Cysts.
|
J Comput Assist Tomogr
|
2016
|
0.75
|
|
160
|
IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers.
|
Ann Surg
|
2016
|
0.75
|
|
161
|
What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcinoma?
|
J Gastrointest Surg
|
2015
|
0.75
|
|
162
|
Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons.
|
HPB (Oxford)
|
2014
|
0.75
|
|
163
|
Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET).
|
Oncotarget
|
2017
|
0.75
|
|
164
|
Surgical intervention for a foreign body trapped in the stomach.
|
Am Surg
|
2015
|
0.75
|
|
165
|
Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.
|
Ann Surg
|
2017
|
0.75
|
|
166
|
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group.
|
Ann Surg
|
2017
|
0.75
|
|
167
|
Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
|
Ann Surg
|
2017
|
0.75
|
|
168
|
Serous Cystadenoma of the Pancreas: Potentials and Pitfalls of a Preoperative Cytopathologic Diagnosis.
|
Acta Cytol
|
2016
|
0.75
|
|
169
|
Pancreaticoduodenectomy after bariatric surgery: challenges and available techniques for reconstruction.
|
J Gastrointest Surg
|
2013
|
0.75
|
|
170
|
Characterization and Optimal Management of High-Risk Pancreatic Anastomoses During Pancreatoduodenectomy.
|
Ann Surg
|
2017
|
0.75
|
|
171
|
Development and Validation of a Multi-Institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
|
Ann Surg
|
2016
|
0.75
|
|
172
|
Oncogenesis in Patients With Pancreatic Intraductal Papillary Mucinous Neoplasms: Taking the Thread From the Beginning.
|
Ann Surg
|
2017
|
0.75
|
|
173
|
General and acute care surgical procedures in patients with left ventricular assist devices.
|
World J Surg
|
2014
|
0.75
|
|
174
|
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula after Distal Pancreatectomy: A Multi-Institutional Analysis and External Validation.
|
Ann Surg
|
2017
|
0.75
|
|
175
|
Circulating Epithelial Cells in Intraductal Papillary Mucinous Neoplasms and Cystic Pancreatic Lesions.
|
Pancreas
|
2017
|
0.75
|